Basis of Kinetics in Clinical Toxicology

  • A. Jaeger
  • C. Berton
  • J. Kempf
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine 1994 book series (YEARBOOK, volume 1994)


In acute poisonings, the toxicological analysis has an interest for the diagnosis, the prognosis and the treatment. An ideal interpretation should answer several questions:
  • are the symptomatology and the prognosis correlated with kinetic data and especially with serum or blood concentrations and plasma half-life?

  • is the kinetic profile in the patient similar or different from the known spontaneous kinetic, and which factors are reponsible for the variations?

  • which patients will benefit from treatments such as decontamination techniques, oral activated charcoal, enhanced drug elimination, and antidotes? and

  • which kinetic parameters will be useful to identify these patients?


Activate Charcoal Acute Poisoning Gastric Lavage Clinical Toxicology Lithium Poisoning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Jaeger A, Sauder P, Kopferschmitt J (1987) Toxicocinétique. In: Bismuth C (ed) Toxicologie clinique, Flammarion, Paris, pp 52–82Google Scholar
  2. 2.
    Jaeger A, Sauder P, Kopferschmitt J, Dahlet M (1990) Toxicokinetics in clinical toxicology. Acta Clin Belg 45(Supp1)13: 1–12Google Scholar
  3. 3.
    Ellenhorn MJ, Barceloux DG (eds)(1988) Medical Toxicology. Diagnosis and treatment of human poisoning. Elsevier, New YorkGoogle Scholar
  4. 4.
    Bismuth C (1987) Toxicologie clinique, Flammarion, ParisGoogle Scholar
  5. 5.
    Olson KR, Benowitz NL, Woo OF, et al (1985) Theophylline overdose: Acute single ingestion versus chronic repeated overmedication. Am J Emerg Med 3: 386–394PubMedCrossRefGoogle Scholar
  6. 6.
    Shannon M, Lovejoy FH (1990) The influence of age vs peak serum concentration on life-treatening events after chronic theophylline intoxication. Arch Intern Med 150: 2045–2048PubMedCrossRefGoogle Scholar
  7. 7.
    Rumack BM, Matthew H (1975) Acetaminophen poisoning and toxicity. Pediatrics 5: 87 1876Google Scholar
  8. 8.
    Proudfoot AT, Stewart SM, Levitt T, Widdop B (1979) Paraquat poisonings. Significance of plasma paraquat concentrations. Lancet 2: 330–332PubMedCrossRefGoogle Scholar
  9. 9.
    Jacobsen D, McMartin KE (1986) Methanol and ethylene glycol poisonings: Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1: 309–334PubMedGoogle Scholar
  10. 10.
    Jaeger A, Jehl F, Flesch F, Sauder P, Kopferschmitt J (1993) Kinetics of amatoxins in human poisoning: Therapeutic implications. Clin Toxicol 31: 63–80CrossRefGoogle Scholar
  11. 11.
    Jaeger A, Sander P, Kopferschmitt J, Tritsch L, Flesch F (1993) When should dialysis be performed in lithium poisoning? Kinetic study in 14 cases of lithium poisoning. Clin Toxicol 31: 429–447CrossRefGoogle Scholar
  12. 12.
    Shannon M, Lovejoy FH (1989) Life-threatening events after theophylline intoxication: A prospective analysis of 144 cases. Ann Emerg Med 18: 446 (Abst)Google Scholar
  13. 13.
    Dyson EH, Simpson D, Prescott LF, Proudfoot AT (1987) Self-poisoning and therapeutic intoxication with lithium. Human Toxicol 6: 325–329CrossRefGoogle Scholar
  14. 14.
    Hickey AR, Wenger TL, Carpenter VP, et al (1991) Digoxin immune Fab therapy in the management of digitalis intoxication: Safety and efficacy results of an observational surveillance study. J Am Coll Cardiol 17: 590–598PubMedCrossRefGoogle Scholar
  15. 15.
    Bayer MJ (1991) Recognition and management of digitalis intoxication: Implications for emergency medecine. Am J Emerg Med 9: 29–32PubMedCrossRefGoogle Scholar
  16. 16.
    Levy G (1979) Pharmacokinetics in man. Drug Metab Rev 9: 3–19PubMedCrossRefGoogle Scholar
  17. 17.
    Ahlmen JA, Heath A, Helitz H, Kvist L, Mellstrand T (1984) Treatment of oral theophylline poisoning. Acta Med Scand 214: 423–426Google Scholar
  18. 18.
    Sauder P, Berton C, Levenes H, Flesch F, Kopferschmitt J (1993) Efficacité toxicocinétique du lavage gastrique. Réan Urg 2: 202–209CrossRefGoogle Scholar
  19. 19.
    Neuvonen PJ, Olkkola KT (1988) Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses. Med Toxicol 3: 33–58Google Scholar
  20. 20.
    Pond SM (1986) Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol 1: 3–11PubMedGoogle Scholar
  21. 21.
    Bismuth C, Gamier R, Baud FJ, Musziynski J, Keyes C (1990) Paraquat poisoning. An overview of the current status. Drug Saf 5: 243–251PubMedCrossRefGoogle Scholar
  22. 22.
    Baud F, Galliot M, Astier A, Bismuth C (1988) Treatment of ethylene glycol poisoning with intravenous 4-methylpyrazole. N Engl J Med 319: 97–100PubMedCrossRefGoogle Scholar
  23. 23.
    Smith TW, Butler VP, Haber E, et al (1982) Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. N Engl J Med 307: 1357–1362PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • A. Jaeger
  • C. Berton
  • J. Kempf

There are no affiliations available

Personalised recommendations